Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Polyclonal Antibodies Industry?

The market size for constipation laxatives has witnessed substantial growth lately. The market is expected to expand from $7 billion in 2024 to $7.37 billion in 2025, delivering a compound annual growth rate (CAGR) of 5.3%. The growth over the historic period is mainly due to the rise in elderly population, reduced physical activity, increased understanding of digestive health, easy availability of laxatives, and a surge in gastrointestinal diseases.

The market size for constipation laxatives is poised for substantial expansion in the forthcoming years, with a projected growth to “$9.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. This growth trajectory during the forecast period can be primarily ascribed to factors such as a higher rate of prescriptions by doctors and pharmacists, regulatory shifts that affect drug approbation, a burgeoning functional foods segment, widened accessibility and procurement of laxatives, along with the emergence of online purchasing platforms. The prominent tendencies during the projection duration encompass advancements in the pharmaceutical sector, refining of manufacturing methodologies, continued exploration into gut health, introduction of novel products, and the origination of composite formulations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16021&type=smp

#Which Factors Are Currently Driving The Growth Of The Polyclonal Antibodies Market?

The rising incidence of cancer is likely to stimulate the expansion of the polyclonal antibodies market in the future. These antibodies play a crucial role in cancer research and treatment by facilitating biomarker recognition, immunohistochemistry, targeted therapy, and immunotherapy, which enhance cancer diagnosis and treatment, thus leading to improved patient outcomes. The surge in cancer patients is a significant contributor to the expansion of the polyclonal antibodies market. For instance, Cancer Australia, an Australian organization that supports cancer patients and raises disease awareness throughout Australia and its territories, reported in September 2022, that 2,572 new cases of stomach cancer (1,661 in men and 911 in women) are anticipated to be diagnosed in 2022. By the time individuals reach the age of 85 in 2022, they face a 1 in 114 (or 0.87%) risk of developing stomach cancer (1 in 1.1 or 87% for men and 1 in 167 or 0.60% for women). Thus, the growing incidence of cancer is a significant driver of the polyclonal antibodies market’s growth.

The constipation laxative market covered in this report is segmented –

1) By Drug Type: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxative, Other Drugs

2) By Route Of Administration: Oral, Rectal

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Bulk-Forming Laxatives: Psyllium, Methylcellulose, Polycarbophil

2) By Stimulant Laxatives: Bisacodyl, Senna, Castor Oil

3) By Osmotic Laxatives: Lactulose, Polyethylene Glycol (PEG), Magnesium-Based Laxatives, Sorbitol

4) By Other Drugs: Lubiprostone, Linaclotide, Plecanatide, Prucalopride

What Notable Trends Are Shaping The Direction Of The Polyclonal Antibodies Market?

Notable corporations in the constipation laxative market are striving to innovate new offerings, for example, liquid ayurvedic laxatives, to cater to customers’ requirements for a tasty yet efficient constipation solution. Liquid ayurvedic laxative, a formulation based on herbs, intends to relieve constipation by encouraging bowel movements and thereby providing a natural choice in the arena of constipation laxatives. For instance, Lupin Life, a pharmaceutical firm from India, in December 2023, introduced Softovac Liquifibre, a pure ayurvedic liquid laxative. The product is a pioneering mix of Isabgol fiber alongside natural actives like Sonamukhi, Harad, Mulethi, Saunf, Amaltas, and Gulab Dal. Softovac Liquifibre, enriched with cutting-edge technologies for perfect particle size and a mango taste, serves as a mild and non-addictive remedy for constipation. It also considers consumer preferences for diabetic-friendly and pleasurable taste.

Who Are The Main Participants Shaping The Polyclonal Antibodies Market Landscape?

Major companies operating in the constipation laxative market are Procter & Gamble Corporation, Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, AstraZeneca PLC, Abott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmBH, Reckitt Benckiser Group plc, Fresenius Kabi AG, Daiichi Sankya Company Limited, Eisai Co. Ltd, Sun Pharmaceutical Ltd, Purdue Pharma LP, Shionogi & Co. Ltd, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Mallinckrodt Pharmaceuticals, Ironwood Pharmaceuticals, Beutlich Pharmaceuticals LLC

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Which Region Currently Holds The Largest Share In The Polyclonal Antibodies Market?

North America was the largest region in the constipation laxative market in 2024. The regions covered in the constipation laxative market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16021&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model